TY - JOUR
T1 - Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice
AU - Myslivecek, Jaromir
AU - Duysen, Ellen G.
AU - Lockridge, Oksana
N1 - Funding Information:
Acknowledgement We thank the Grant Agency of Charles University for funding (grant GAUK 519/07) and to US Army Medical Research and Materiel Command (Grant DAMD17–01–2–0036 (to O.L.) and UNMC Eppley Cancer Center Support Grant P30CA36727. The excellent technical assistance of Miss Eva Simakova is acknowledged.
PY - 2007/10
Y1 - 2007/10
N2 - The acetylcholinesterase knockout mouse has elevated acetylcholine levels due to the complete absence of acetylcholinesterase. Our goal was to determine the adaptive changes in lung receptors that allow these animals to tolerate excess neurotransmitter. The hypothesis was tested that not only muscarinic receptors but also α1-adrenoceptors and β-adrenoceptors are downregulated, thus maintaining a proper balance of receptors and accounting for lung function in these animals. The quantity of α1A, α1B, α1D, β1, and β2-adrenoceptors and muscarinic receptors was determined by binding of radioligands. G-protein coupling was assessed using pseudo-competition with agonists. Phospholipase C activity was measured by an enzymatic assay. Cyclic AMP (cAMP) content was measured by immunoassay. Muscarinic receptors were decreased to 50%, α1-adrenoceptors to 23%, and β-adrenoceptors to about 50% of control. Changes were subtype specific, as α1A, α1B, and β2-adrenoceptors, but not α1D-adrenoceptor, were decreased. In contrast, receptor signaling into the cell as measured by coupling to G proteins, cAMP content, and PI-phospholipase C activity was the same as in control. This shows that the nearly normal lung function of these animals was explained by maintenance of a correct balance of adrenoceptors and muscarinic receptors. In conclusion, knockout mice have adapted to high concentrations of acetylcholine by downregulating receptors that bind acetylcholine, as well as by downregulating receptors that oppose the action of muscarinic receptors. Tolerance to excess acetylcholine is achieved by reducing the levels of muscarinic receptors and adrenoceptors.
AB - The acetylcholinesterase knockout mouse has elevated acetylcholine levels due to the complete absence of acetylcholinesterase. Our goal was to determine the adaptive changes in lung receptors that allow these animals to tolerate excess neurotransmitter. The hypothesis was tested that not only muscarinic receptors but also α1-adrenoceptors and β-adrenoceptors are downregulated, thus maintaining a proper balance of receptors and accounting for lung function in these animals. The quantity of α1A, α1B, α1D, β1, and β2-adrenoceptors and muscarinic receptors was determined by binding of radioligands. G-protein coupling was assessed using pseudo-competition with agonists. Phospholipase C activity was measured by an enzymatic assay. Cyclic AMP (cAMP) content was measured by immunoassay. Muscarinic receptors were decreased to 50%, α1-adrenoceptors to 23%, and β-adrenoceptors to about 50% of control. Changes were subtype specific, as α1A, α1B, and β2-adrenoceptors, but not α1D-adrenoceptor, were decreased. In contrast, receptor signaling into the cell as measured by coupling to G proteins, cAMP content, and PI-phospholipase C activity was the same as in control. This shows that the nearly normal lung function of these animals was explained by maintenance of a correct balance of adrenoceptors and muscarinic receptors. In conclusion, knockout mice have adapted to high concentrations of acetylcholine by downregulating receptors that bind acetylcholine, as well as by downregulating receptors that oppose the action of muscarinic receptors. Tolerance to excess acetylcholine is achieved by reducing the levels of muscarinic receptors and adrenoceptors.
KW - Acetylcholinesterase knockout
KW - Adrenoceptors
KW - Muscarinic receptors
KW - Tolerance
UR - http://www.scopus.com/inward/record.url?scp=38449085927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38449085927&partnerID=8YFLogxK
U2 - 10.1007/s00210-007-0184-4
DO - 10.1007/s00210-007-0184-4
M3 - Article
C2 - 17805515
AN - SCOPUS:38449085927
SN - 0028-1298
VL - 376
SP - 83
EP - 92
JO - Naunyn-Schmiedeberg's Archives of Pharmacology
JF - Naunyn-Schmiedeberg's Archives of Pharmacology
IS - 1-2
ER -